Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference
Get Alerts TEM Hot Sheet
Join SI Premium – FREE
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California.
Tempus Founder and CEO Eric Lefkofsky will deliver a presentation, followed by a live Q&A session, on January 12th, 2026 from 1:30 - 2:10PM PST. The presentation will be available via live webcast here:
About Tempus
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260106129559/en/
Hanah Heintzelman
[email protected]
Source: Tempus AI, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- e.l.f. Expands Into Fragrance and Body Care Categories with Launch of e.l.f. POP, Debuting Limited-Edition Holiday “Spicy Bundt Nice” Collection Inspired by Tromsø, Norway
- True Food Kitchen Initiates Voluntary Chapter 11 Proceedings to Position Business for Long-Term Success
- Green Rain Energy Holdings Engages FG Relations to Expand Investor Communications Across Europe and the United States
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share